secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2023-07-25T23:59:59+00:00
Accession:  0001157523-23-001145
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q2 net sales $238M (-10% YoY), EPS $0.89; FY2023 guidance raised at low end
--------------------------------------------------------------------------------

- Q2 net sales $238M, down 10% YoY; diluted EPS $0.89 vs $1.00.
- Active customers 487k, down 13% YoY; sequential rise in mainland China customers (+5%).
- FY2023 guidance: net sales $900-950M (prev $875-950M), EPS $2.65-3.30 (prev $2.40-3.30).
- Greater China net sales $129M, +4% sequential; mainland China local-currency sales +10% QoQ.
- Plans to open 25th market, India, in late 2023; first new market since 2018.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752323001145/0001157523-23-001145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752323001145/a53479151.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-001145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer